[
1. Sharma A, Ahmad Farouk I, Lal SK. COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention. Viruses. 2021 Jan;13(2).10.3390/v13020202791153233572857
]Search in Google Scholar
[
2. Pyrc K, Berkhout B, van der Hoek L. The novel human coronaviruses NL63 and HKU1. J Virol. 2007 Apr;81(7):3051–7.10.1128/JVI.01466-06186602717079323
]Search in Google Scholar
[
3. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33.10.1056/NEJMoa2001017709280331978945
]Search in Google Scholar
[
4. Elena SF, Sanjuán R. Adaptive value of high mutation rates of RNA viruses: separating causes from consequences. J Virol. 2005 Sep;79(18):11555–8.10.1128/JVI.79.18.11555-11558.2005121261416140732
]Search in Google Scholar
[
5. Duffy S. Why are RNA virus mutation rates so damn high? PLoS Biol. 2018;16.10.1371/journal.pbio.3000003610725330102691
]Search in Google Scholar
[
6. Hoque MN, Chaudhury A, Akanda MAM, Hossain MA, Islam MT. 2020. Genomic diversity and evolution, diagnosis, prevention, and therapeutics of the pandemic COVID-19 disease. PeerJ 8:e968910.7717/peerj.9689751047733005486
]Search in Google Scholar
[
7. Del Rio C, Omer SB, Malani PN. Winter of Omicron-The Evolving COVID-19 Pandemic. JAMA. 2022 Jan;327(4):319–20.10.1001/jama.2021.2431534935863
]Search in Google Scholar
[
8. Yu F, Lau L-T, Fok M, Lau JY-N, Zhang K. COVID-19 Delta variants—Current status and implications as of August 2021. Precis Clin Med. 2021 Dec 22;4(4):287–92.10.1093/pcmedi/pbab024849999535692860
]Search in Google Scholar
[
9. To KKW, Hung IFN, Chan JFW, Yuen K-Y. From SARS coronavirus to novel animal and human coronaviruses. J Thorac Dis. 2013 Aug;5 Suppl 2(Suppl 2):S103–8.
]Search in Google Scholar
[
10. Prathipati KK, Mishra M, Rathod B, Tripathy JP, B H S, Bidkar V, et al. Symptomatology and Relationship Between Symptoms and Duration Among COVID-19 Patients in a COVID-19 Care Hospital in Central India. Cureus. 2022 Jan;14(1):e21541.10.7759/cureus.21541886559835223314
]Search in Google Scholar
[
11. Miró Ò, Jiménez S, Mebazaa A, Freund Y, Burillo-Putze G, Martín A, et al. Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome. Eur Heart J. 2021 Sep 1;42(33):3127–42.10.1093/eurheartj/ehab314834471434164664
]Search in Google Scholar
[
12. Roncon L, Zuin M, Barco S, Valerio L, Zuliani G, Zonzin P, et al. Incidence of acute pulmonary embolism in COVID-19 patients: Systematic review and meta-analysis. Eur J Intern Med. 2020 Dec;82:29–37.10.1016/j.ejim.2020.09.006749825232958372
]Search in Google Scholar
[
13. Pellicori P, Doolub G, Wong CM, Lee KS, Mangion K, Ahmad M, et al. COVID-19 and its cardiovascular effects: a systematic review of prevalence studies. Cochrane Database Syst Rev. 2021;(3).10.1002/14651858.CD013879807834933704775
]Search in Google Scholar
[
14. Fauvel C, et all. Pulmonary embolism in COVID-19 patients: a French multicentre cohort study. Eur Heart J 2020;41:3058–3068.10.1093/eurheartj/ehaa500752895232656565
]Search in Google Scholar
[
15. Saeed GA, Gaba W, Shah A, Al Helali AA, Raidullah E, Al Ali AB, et al. Correlation between Chest CT Severity Scores and the Clinical Parameters of Adult Patients with COVID-19 Pneumonia. Radiol Res Pract. 2021;2021:6697677.10.1155/2021/6697677780194233505722
]Search in Google Scholar
[
16. Hafez MAF. The mean severity score and its correlation with common computed tomography chest manifestations in Egyptian patients with COVID-2019 pneumonia. Egypt J Radiol Nucl Med. 2020;51(1):254.10.1186/s43055-020-00368-y
]Search in Google Scholar
[
17. Elberts SJ, Bateman R, Koutsoubis A, London KS, White JL, Fields JM. The impact of COVID-19 on the sensitivity of D-dimer for pulmonary embolism. Acad Emerg Med. 2021;28(10):1142–9.10.1111/acem.14348865309334425044
]Search in Google Scholar
[
18. Ventura-Díaz S, Quintana-Pérez J V, Gil-Boronat A, Herrero-Huertas M, Gorospe-Sarasúa L, Montilla J, et al. A higher D-dimer threshold for predicting pulmonary embolism in patients with COVID-19: a retrospective study. Emerg Radiol. 2020;27(6):679–89.10.1007/s10140-020-01859-1753826633025219
]Search in Google Scholar
[
19. Portier I, Campbell RA, Denorme F. Mechanisms of immunothrombosis in COVID-19. Curr Opin Hematol. 2021;28(6):445–53.10.1097/MOH.0000000000000666849028234232139
]Search in Google Scholar
[
20. Iba T, Connors JM, Levy JH. The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Inflamm Res. 2020;69(12):1181–9.10.1007/s00011-020-01401-6748658632918567
]Search in Google Scholar
